Samantha Gao-Sheridan, based in Cambridge, Massachusetts, United States, is currently a Vice President, Head of Global Regulatory Affairs CMC at PTC Therapeutics, Inc., bringing experience from previous roles at Alnylam Pharmaceuticals, Shire Pharmaceuticals, Shire Human Genetic Therapies and Wyeth Biotech. Samantha Gao-Sheridan holds a PhD in Biochemistry and Molecular Biology @ UC Irvine. With a robust skill set that includes Protein Chemistry, IND, Regulatory Affairs, Monoclonal Antibodies, CMC and more, Samantha Gao-Sheridan contributes valuable insights to the industry. Samantha Gao-Sheridan has 1 email on RocketReach.